RAD51 and breast carcinoma: In ovarian and breast cancer experimental models, including ex vivo cultures derived from ascites or solid HGSOC, decreased DNA damage-induced nuclear RAD51 foci have been associated with BRCA1 or BRCA2 gene deficiencies and PARPi responses [68].